These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 5721222)
1. [On various derivatives of mefenamic and flufenamic acids]. Spanò R; Marri R Boll Chim Farm; 1968 Aug; 107(8):512-5. PubMed ID: 5721222 [No Abstract] [Full Text] [Related]
2. [Pharmacological properties of a series of derivatives of mefenamic and flufenamic acids]. Linari G; Spanò R Farmaco Sci; 1971 Apr; 26(4):303-11. PubMed ID: 5559990 [No Abstract] [Full Text] [Related]
3. [Analytical reactions of mefenamic and flufenamic acids]. Devaux G; Mesnard P; Brisson AM Ann Pharm Fr; 1969 Mar; 27(3):239-48. PubMed ID: 5400246 [No Abstract] [Full Text] [Related]
4. [The new anti-inflammatory acids. Niflumic acid in rheumatology]. Camus JP Presse Med (1893); 1968 May; 76(22):1071-2. PubMed ID: 5300745 [No Abstract] [Full Text] [Related]
6. Experimental observations on flufenamic, mefenamic and meclofenamic acids. 3. Metabolic disposition. Glazko AJ Ann Phys Med; 1966; Suppl():23-36. PubMed ID: 4979052 [No Abstract] [Full Text] [Related]
7. [Antirheumatics in a narrower sense]. Gross D Ther Umsch; 1972 Aug; 29(8):502-4. PubMed ID: 4538298 [No Abstract] [Full Text] [Related]
8. [Contribution to the evaluation of anti-inflammatory agents in vitro]. Mörsdorf K; Cornelissen G Med Pharmacol Exp Int J Exp Med; 1966; 15(4):399-403. PubMed ID: 6012770 [No Abstract] [Full Text] [Related]
9. Glucuronidation of fenamates: kinetic studies using human kidney cortical microsomes and recombinant UDP-glucuronosyltransferase (UGT) 1A9 and 2B7. Gaganis P; Miners JO; Knights KM Biochem Pharmacol; 2007 May; 73(10):1683-91. PubMed ID: 17343829 [TBL] [Abstract][Full Text] [Related]
10. Experimental observations on flufenamic, mefanamic and meclofenamic acids. II. Toxicology in animals. Kaump DH Ann Phys Med; 1966; Suppl():16-23. PubMed ID: 4979051 [No Abstract] [Full Text] [Related]
11. Tolfenamic acid. Detection and structure of urinary metabolites. Pedersen SB; Alhede B; Buchardt O; Møller J; Bock K Arzneimittelforschung; 1981; 31(11):1944-8. PubMed ID: 7198475 [TBL] [Abstract][Full Text] [Related]
12. Optical studies of drug-protein complexes. 3. Interaction of flufenamic acid and other N-arylanthranilates with serum albumin. Chignell CF Mol Pharmacol; 1969 Sep; 5(5):455-62. PubMed ID: 5823761 [No Abstract] [Full Text] [Related]
13. Discussion on clinical trials of the fenamates. Ann Phys Med; 1966; Suppl():129-34. PubMed ID: 5306340 [No Abstract] [Full Text] [Related]
14. Experimental observations on flufenamic, mefenamic, and meclofenamic acids. IV. Toleration by normal human subjects. Holmes EL Ann Phys Med; 1966; Suppl():36-49. PubMed ID: 4895006 [No Abstract] [Full Text] [Related]
16. [Flufenamic acid]. Südhof H Dtsch Med Wochenschr; 1968 Dec; 93(50):2455. PubMed ID: 5698984 [No Abstract] [Full Text] [Related]
17. Mefenamic acid (ponstel). Med Lett Drugs Ther; 1967 Oct; 9(20):77-8. PubMed ID: 6052701 [No Abstract] [Full Text] [Related]
18. Antagonism by mefenamic and flufenamic acids of the bronchoconstrictor action of kinins in the guinea-pig. COLLIER HO; SHORLEY PG Br J Pharmacol Chemother; 1963 Apr; 20(2):345-51. PubMed ID: 14022332 [TBL] [Abstract][Full Text] [Related]
19. [Clinical study of a new anthranilic acid derivative: flufenamic acid]. Colombo B; Chériè Lignière G; Mantellini P Reumatismo; 1969; 21(3):114-21. PubMed ID: 4929605 [No Abstract] [Full Text] [Related]